Clinical Trial Update: Cell Therapy In Dilated Cardiomyopathy [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 clinical trial evaluating a cell therapy for dilated cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy

Snippet

Sponsor: Ministry of Health, Brazil | Conditions: Dilated Cardiomyopathy | Phase 3 | Status: COMPLETED